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In a variety ofexperimental and natural illnesses ofanimals and man involving
the central nervous system (CNS)' immunoglobulin (1g) is produced intrathecally
(1-4). Intracerebral Igproduction has been seen in acuteand subacute infectious
diseases (5-9) but is more often observed when the courses are chronic. In
multiple sclerosis, the infectious nature of which is debated but not established
(10), antibodies with sundry specificities have been detected (11-13), while
during illnesses with known etiologies antibodies against the causative agents are
predominantly formed (14, 15). In certain slow virus diseases this phenomenon
seems to be a regular feature, and in subacute sclerosing panencephalitis (SSPE)
(16-18), progressive rubella panencephalitis (19, 20), and visna (21, 22), anti-
bodies directed against measles, rubella, and visna viruses, respectively, have
been shown to be produced intracranially.
For humoral immune responses, several cell types must cooperate; hence,
antibody production in the CNS would require that these cells not only migrate
there but also assemble locally. In cases of multiple sclerosis, the CNS has been
reported to contain tissue resembling the Ig-secreting medullary regions of the
lymph nodes (23), but whether cells ofthe immune system are similarly arranged
in a chronic brain disease caused by a persistent virus infection seems to be
unknown. Nor do we know how cells ofthe immune system find their way into
the CNS, and no explanation can at present be given for the apparent longevity
ofcertain B cell clones under these conditions (24, 25).
After connatal or neonatal infection ofa mouse, the lymphocytic choriomen-
ingitis virus (LCMV) persists lifelong in high concentrations in essentially all
organs (26). Inability to eliminate the virus is assumed to result from LCMV-
specific immunologic tolerance ofthe T cell compartment (27); antibodies against
the virus may be produced and form complexes with virus that are thought to
cause an immune complex disease (ICD) often seen in aging carrier mice (28).
In the parenchymatous organs of these mice, including the CNS, there are
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accumulations of mononuclear cells (29-31) that may be so extensive as to
resemble lymphomas. We now report that these infiltrates contain numerous
plasma cells but also lymphocytes and mononuclear phagocytes, and, by use of a
recently developed procedure (32, 33), we have demonstrated in the same organs
cells forming LCMV-specific Ig (antiviral antibody-forming cell ; AFC). Accu-
mulations of lymphoid tissue, and numbers of AFC in parenchymatous organs,
as well as ICD were found to be quantitatively correlated among mouse strains.
The LCMV carrier mouse should prove to be a useful model with which to study
the ectopic production of antiviral antibodies during slow virus diseases with and
without involvement of the CNS.
Materials and Methods
Mice. CBA/J (CBA), C3H/Hej (C3H), AKR/J, C57BR/cdj, and B10.BR/SgSnj (all
H-2k), C57BL/I OSnJ (1310) (H-26), and DBA/lLacJ (H-29) mice were purchased from The
Jackson Laboratory (Bar Harbor, ME) and SWR/Ola (SWR)and BI 0.G/Ola (BI O.G) mice
(both H-29) from OLAC 1976, Ltd. (Blackthorn, Bicester, United Kingdom). NMRI
inbred mice, originally obtained from the Medical Research Council Laboratory Animals
Centre, Carshalton (Surrey, United Kingdom) were bred in this institute by continual
brother-sister mating; their haplotype has been determined (personal communication) by
K. Fischer-Lindahl (Basel) as H-29. Gray house mice (haplotype unknown) came from our
own colony originating from wild animals trapped in northern Germany.
Virus.
￿
The WE strain LCMV (34) was used after it had been plaque purified three
times; it was propagated and titrated in L cells and expressed as mouse infectious units
(IU), IU beingnumerically identical with 50% mouse infectious dose (35).
CarrierMice.
￿
The neonatal carrier status was induced by inoculating intraperitoneally
10' IU of LCMV 24 h or less after birth (36). The carrier house mice came from a colony
established 10 yr ago with organ homogenate from a persistently infected wild mouse.
Histologic and Immunohistologic Procedures.
￿
Pieces of kidneys, livers, and brains were
excised from the same organs that were subsequently processed for the enumeration of
AFC. After fixation either in acid formaldehyde (37) or Bouin's solution, they were
embedded in Paraplast, and sections were stained with hematoxylin-eosin, periodic acid-
Schiff, or Giemsa stain. In a few instances brains were fixed by perfusion and embedded
in glycol-methacrylate (Technovit; Kulzer, Friedrichsdorf, Federal Republic of Germany),
and semithin sections were stained with toluidine blue.
For demonstrating Ig, the peroxidase-antiperoxidase (PAP) technique (38) was used.
Sections were rehydrated and treated with 0.01 % protease type VII (Sigma Chemical Co.,
Deisenhofen, Federal Republic of Germany) or 3 M urea (Merck, Darmstadt, Federal
Republic of Germany) in 0 .05 M Tris-buffered salt solution at pH 7.6. Overnight
incubation with suitably diluted affinity-purified antibodies against heavy chains of either
mouse IgG raised in rabbit (Jackson, Avondale, PA) or mouse IgM raised in goat (Pel-
Freez, Rogers, AR) was followed by incubation with antibody directed against rabbit or
goat Ig (Nordic, Tilburg, The Netherlands), respectively. The PAP complex (Dakopatts,
Glostrup, Denmark) was then applied, and peroxidase was visualized by the method of
Graham and Karnovsky (39) using 3,3'-diamino-benzidine-tetrahydrochloride (Fluka,
Buchs, Switzerland) as cosubstrate.
Detection of Cells Forming Anti-LCMV Antibodies.
￿
AFC were released enzymatically
from parenchymatous organs and enumerated by use of a solid-phase immunoenzymatic
technique. Trypsin (Difco Laboratories, Detroit, MI) was prepared according to Wallis
and his colleagues (40) and diluted before use to 0.25% with Eagle's MEM (no serum).
Kidneys, livers, and brains (and for control purposes spleens) from carrier mice were cut
into small cubes and subsequently digested by 3 (livers, brains, and spleens) and 12
(kidneys) successive 15-min periods of gentle agitation with trypsin solution at 25°C.
Released cells were concentrated by centrifugation and leukocytes were separated by
Ficoll-Isopaque density centrifugation (41) and counted as living on the basis of trypanMOSKOPHIDIS ET AL. 707
blue exclusion. To search forAFC in the circulation, blood was collected by venipuncture
and leukocytes were separated by use of Ficoll-Isopaque. Subsequently, AFC were enum-
erated as has been described for the spleen (33). Leukocytes were serially diluted and
seeded onto the surfaces of virus-coated 2 X 2-cm wells of 25-square polystyrene dishes.
After 5 h of incubation at 37'C, the cells were rinsed offwith PBS containing Tween 20.
Optimally diluted rabbit anti-mouse Ig (IgM + IgG + IgA) (Zymed Laboratories, San
Francisco, CA), anti-IgM (Miles Scientific, Munchen, Federal Republic of Germany), or
anti-IgG (Zymed Laboratories) was added to the wells, which were incubatedagain for 2
h. They were rinsed and antibody-alkaline phosphatase conjugate (Tago, Burlingame,
CA) was added. The plates were left at room temperature overnight and, after further
rinsing, agarose containing the p-toluidine salt of 5-bromo-4-chloro-3-indolyl phosphate
(Sigma Chemical Co.) was pipetted onto the surfaces. After incubation for I h at 37 °C,
blue spots corresponding to AFC could be counted.
Detection of Cells Producing Antibodies of Undetermined Specficities.
￿
The assay was
performed as described above for AFC, except that the antigen with which the wells were
coated was goat anti-mouse H- and L-chain-specific Ig (IgG + IgM + IgA) (Zymed
Laboratories) instead of purified LCMV.
Results
Histological and Immunohistochemical Observations in Carrier Mice.
￿
Aging mice
of 7 of the 11 strains included in this study, namely NMRI, SWR, DBA/1LacJ,
1110, C57BR/cdJ, B10.G, and B10.BR/SgSnj developed a characteristic syn-
drome, which had previously been known as late-onset disease(29), and has more
recently been identified as ICD (28). Because it has been extensively reviewed
(27), no details will be presented here. Persistently infected C3H, CBA, AKR/J,
and house mice remained outwardly healthy throughout the period of observa-
tion and histologically presented at most low-grade alterations.
In addition to the changescaused by deposition of antigen-antibody complexes,
in carrier mice undergoing ICD essentially all organs contained mostly nodular
infiltrates of mononuclear cells that varied considerably in size and structural
organization. Here we confine ourselves to the organs chosen for the quantitative
determination ofcellsproducing antiviral antibodies. In the kidney the infiltrates
were mostly localized in the perivascular space of the arcuate arteries and veins
in the juxtamedullary zone (Fig. 1), from where they extended into the loose
connective tissue of the pelvis. Areas with small lymphocytes containing darkly
stained nuclei were separated from areas populated predominantly by larger cells
with bright nuclei and varying degrees of cytoplasmic basophilia. Besides lymph-
oid cells, macrophages and histiocytes could be recognized, and mitotic figures
were frequently seen . The peripheral zones were characterized by the accumu-
lation of numerous plasma cells. In larger infiltrates, newly formed small blood
vessels were seen passing through. In the liver the infiltrates' predominant
localization was the perivascular space of the portal vein; in structure they were
similar to the ones in the kidney but, as a rule, smaller in size.
In the CNS the infiltrates were predominantly localized in the leptomeninx,
from where they extended with the Virchow-Robin spaces into the brain;
occasionally they were found independent of vessels in the parenchyma itself. As
in the other organs, they consisted of plasma cells, small and large lymphocytes,
and mononuclear phagocytes. In shape, they varied considerably, probably as a
consequence of the complex anatomical situation created by the deep, narrow,
and ramified fissures separating the single parts of the brain and the subarachnoid708 ECTOPIC ANTIBODY PRODUCTION IN PERSISTENT VIRUS INFECTION
FIGURE 1 .
￿
Kidney ofa 12-mo-oldLCMV NMRI carriermouse with a large nodular infiltrate
in the perivascular space ofan arcuate artery . Around the blood vessel there are mainly small
lymphocytes with dark nuclei, while elsewhere larger lymphocytes with bright nuclei ofvarying
sizes and abundant basophilic cytoplasm predominate . The arrows point to accumulations of
plasma cells in the periphery of the infiltrate. Giemsa stain . x 300.
space as it accompanies each vessel together with the leptomeninx into thedepth
of the tissue (Fig . 2a) .
With increasing age of the carrier mice and parallel with the severity of the
ICD, the lymphoid infiltrates expanded in both number and size . In mice not
suffering from ICD, lymphoid infiltrates were never found .
Immunohistochemical staining for Ig revealed small numbers of plasmacytes
secreting IgM (Fig . 3), although many cells in the inner parts of the infiltrates
exhibited IgM surface staining . In contrast, IgG-secreting plasma cells were
numerous, especially in the periphery (Figs. 2 b and 4) . Further findings with a
large number of monoclonal antibodies revealed that all cell types believed to be
needed for antibody production were present in these infiltrates {J . Lohler, D.
Moskophidis, and F. Lehmann-Grube, manuscript in preparation).
Antibody-producing Cells in Organs of Carrier Mice.
￿
The demonstration of
production of Ig in the focal accumulations of mononuclear cells in the organs
of carrier mice led to an investigation of its specificity . Tissues were dispersed
by digestion with trypsin, and the ability of separated leukocytes to form anti-
LCMV antibodies was determined . Representative findings for five mouse strains
are presented in Tables I and II . Relatively few leukocytes produced IgM class
antibodies, although it is noteworthy that there were any . Many more leukocytes
released from parenchymatous organs of carrier mice produced virus-specific
IgG class antibodies, and there was a clear quantitative correlation with theMOSKOPHIDIS ET AL .
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FICURE 2.
￿
Brain in the region of the fissura hippocampi of a 14-mo-old LCMV NMRI
carrier mouse . (a) The perivascular, subarachnoid space of a cerebral vein (V) is infiltrated by
lymphocytes, plasma cells, immature preplasma cells, and macrophages. The black arrows
point to mitosesand the white arrow marks the membrana limitans gliae superficialis of the
brain tissue. Sernithin section stained with toluidine blue . x 1,000 . (b) IgGproducing plasma
cells are localized predominantly in the periphery of the infiltrate around leptomeningeal
vessels (V). IgG is also deposited in astrocytic foot processes of the membrana limitans gliae
superficialis (arroyos). PAP technique, no counterstaining of nuclei . x 500 .710 ECTOPIC ANTIBODY PRODUCTION IN PERSISTENT VIRUS INFECTION
FIGURE 3 .
￿
Kidney of a 12-mo-old LCMV carriermouse stained for IgM . Sequential section
of the infiltrate depicted in Figs . 1 and 4 . Small numbers of IgM' plasma cells are scattered
throughout the infiltrate, but the area around the artery is conspicuously free . In the walls of
blood vessels there is subendothelial deposition of IgM (arrows) . PAP technique, slight
counterstaining with hemalaun . X 300 .
appearance of lymphoid infiltrates (which, in turn, was correlated with ICD),
meaning that numbers of AFC were higher in NMRI, SWR, and B10.G mice
than in C3H and CBA mice and increased with the animals' age . As for the
organs, the figures vary greatly, with comparable numbers in spleen, kidney, and
brain . The organs of connatal carrier house mice were essentially devoid ofAFC
(Table I1I) . In all mice, the blood was free of cells producing antibodies against
the virus .
The observations on further mouse strains thus investigated, together with the
histologic findings,are summarized in Table IV . As a rule, carrier mice possessing
the haplotype H-2q had extensive cell infiltrates and high numbers of AFC in
parenchymatous organs and developed severe ICD, while carrier mice of haplo-
type H-2k had few and small infiltrates and low numbers of AFC, and exhibited
minimal degrees of ICD. There are, however, noteworthy exceptions :
C57BR/cdJ and B10.BR/SgSnj mice, although of H-2k haplotype, were high
responders for all three criteria ; apparently, the major histocompatibility gene
complex is not alone responsible for antibody production in LCMV carrier mice .
It was, a priori, likely that not all plasma cells of the infiltrates would form
antibodies against LCMV . Their proportion among the total of active elements
(meaning cells producing antibodies of any specificity) was determined in per-
sistently infected NMRI and B10.G mice (Table V) . It was low in the spleen,MOSKOPHIDIS ET AL .
￿
'111
FIGURE 4 .
￿
Kidney of a 12-mo-old LCMV carrier mouse stained for IgG. Sequential section
of the infiltrate depicted in Figs . 1 and 3 . Numerous mature IgG+ plasma cells and immature
preplasma cells with faint IgG-specific labeling of their cytoplasm are concentrated in the
periphery and the inner parts of the infiltrate, respectively . As in the case of IgM+ cells (Fig .
3),azone around the artery is free of labeled cells. PAP technique, slight counterstaining with
hemalaun . X 300 .
relatively high in kidney and liver, and highest in the brain, where in individual
mice, up to 90% of all Ig-forming cells formed antibodies directed againstLCMV .
The data ofTableV were obtained by use in the first overlay of an antiserum
containing antibodies against mouse IgG, IgM, and IgA . In these experiments,
cells producing LCMV-specific IgM and IgG antibodies were counted in parallel
(not shown) . The sums of their numbers were slightly lower than the numbers
determined using the antiserum directed against three classes ofmouse antibod-
ies, indicating that few of the active cells produced IgA antibodies .
Discussion
It has long been known that, during an infectious disease or under experimen-
tal conditions, Ig may be formed outside the lymphatic tissue . In a thorough
review published in 1968, Heremans (4) summarized the then-available evidence
for antibody formation in a number of different tissues . Of the CNS he wrote
"although proof is lacking, one may presume that the monoclonal immunoglob-
ulins found in CSF from patients with infectious or parasitic diseases of the
central nervous system represent intrathecally synthesized antibodies directed
against the offending antigen." In the meantime, further details have become
known, but direct proof for antibody production within the CNS is still lacking.712 ECTOPIC ANTIBODY PRODUCTION IN PERSISTENT VIRUS INFECTION
TABLE I
Numbers of Cells Producing IgM Anti-LCMVAntibodies in
Organs ofMice Persistently Infected with LCMV
Neonatal carrier mice established by infection within 24 h after birth.
' Below detectability.
t Numbers ofantibody-producing cells per 106 trypan blue-excluding leukocytes, means±SE in three to six mice.
The question then is whether the findings presented here prove that antiviral
antibodies are produced within the CNS (and within other parenchymatous
organs) of LCMV carrier mice.
LCMV carrier mice are apparently devoid of LCMV-specific cytotoxic T
lymphocytes, which seems to be the basis oftheir inability to eliminate the virus
(27), but virus-specific antibodies are produced and form complexes with virus
that are held responsible for a late-appearing ICD (28). Whereas the virus titers
are comparable in the organs ofcarrier mice ofdifferent strains (42), circulating
antibodies vary considerably and are correlated with circulating immune com-
plexes (43); presumably, the quantity of the latter is a function of the quantity
of the former. As it is likely that the amounts of circulating immune complexes
determine the severity of the illness they cause, a correlation probably exists
between circulating antibodies and ICD, an assumption borne out by findings in
two mouse strains (44).
Organs of carriers of certain mouse strains often contain extensive cell infil-
trates harboring many plasma cells, which have been regarded as an expression
of pathologic cell-mediated immune reactions (31) or of some immunoprolifer-
ative disease process(30). Possibly these infiltratesare thebasis forthesometimes-
Mouse
strain
Organ
7 19 26
Age (wk)
31 36 42 58
NMRI Brain <* -3 -28 ^-35 -52 -5 60 t 45
Kidney < -15 < 68 t 26 -26 -45 262 t 130
Liver 5 t 1$ -5 -3 115 t 54 55 t 22 ^-45 --41
Spleen 204 t 132 -38 68 t 23 285 t 122 190 :t 48 280 t 90 -160
Blood < < < < < < <
SWR Brain < --2 < --5 -5 < ND
Kidney < < -5 < < -6 ND
Liver < < < < < --6 ND
Spleen -34 70 t <1 30 t 6 -12 < < ND
Blood < < < < < < ND
BI O.G Brain -20 -9 ND 17 ND 84 t 16 ND
Kidney < 38 t 12 ND ^-67 ND < ND
Liver -30 20 t 10 ND 41 t 27 ND 180 t 120 ND
Spleen 215 t 175 275 t 85 ND 38 t 14 ND 500 t 320 ND
Blood < < ND < ND < ND
C3H Brain < < < -10 -10 -5 ND
Kidney < < < -15 < < ND
Liver < < < < -5 < ND
Spleen < 33 t 9 -3 175 t 5 40 t <1 180 :t 40 ND
Blood < < < < < < ND
CBA Brain < < < < -10 < <
Kidney < < --10 < < --20 -10
Liver < < < < < < <
Spleen 2±<1 < < 24 ± 12 < 40 t 10 <
Blood < < < < < < <Mouse
strain
TABLE II
Numbers of Cells ProducingIgG Anti-LCMVAntibodies in Organs of
Mice Persistently Infected with LCMV
Organ
MOSKOPHIDIS ET AL.
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Age (wk)
7
￿
19 26 81 86
￿
42
￿
58
Neonatal carrier mice established by infection within 24 h after birth.
" Below detectability.
Numbers ofantibody-producing cells per 106 trypan blue-excluding leukocytes, means 3SE in three to six mice.
TABLE III
Numbers of Cells ProducingIgM and IgG Anti-LCMV Antibodies in Organs of
House Mice Persistently Infected with LCMV
Connatal carriermice from acolony established 9yr agowith organhomogenate from apersistently
infected wild house mouse.
* Below detectability.
$ Numbers of antibody-producing cells per 106trypan blue-excluding leukocytes, means ±SEin two
mice.
NMRI Brain
Kidney
Liver
Spleen
Blood
-9
<+
8 t <lt
196 t 108
<
278 t 169
-199
45 t 9
148 t 45
<
908 t 119
^-125
^-21
978 t 89
<
564 t 270
278 t 99
-295
655 t 59
<
619 i 109
-80
99 t 26
969 t 104
<
646 t 287
907 t 116
140 t 49
560 t 168
-4
648 t 479
1,070 t 761
90 t 38
687 t 948
<
SWR Brain 55 t 2 102 t 86 60 t 21 520 t 259 555 t 992 654 t 210 ND
Kidney -60 264 t 25 100 t 54 -198 920 t 110 929 t 199 ND
Liver --10 109 t 20 "20 -25 < -149 ND
Spleen 296 t 80 284 t <1 967 t 29 -50 58 t 17 167 t 79 ND
Blood < < < < < < ND
BIO.G Brain 40 t <I 819 3 299 ND 608 t 42 ND 1,958 t 87 ND
Kidney ^-15 450 t 250 ND 600 t 1 ND 625 t 125 ND
Liver 40 t 20 70 t <1 ND 164 3 88 ND 215 t 65 ND
Spleen 520 t 180 510 t 190 ND 498 t 14 ND 655 t 995 ND
Blood < < ND < ND < ND
C3H Brain < < < < 55 ± 85 -10 ND
Kidney < < -10 95 ± 15 < 15 t 5 ND
Liver < 4 t 0.5 < < < ^5 ND
Spleen < 62 t 6 90 t 10 95 t 25 25 t 15 105 t 15 ND
Blood < < < < < < ND
CBA Brain < < < < -10 < <
Kidney < < < -109 ^-5 20 :k <1 <
Liver < < < 61 1 28 -40 10±<l <
Spleen 8 t <l < < 87 ± 5 < 35 3 25 <
Blood < < < < < < <
Organ IgM
Age of mice (wk)
IgG
8 26 44 64 77 8 26 44 64 77
Brain <* < < < 55 ± 40$ < < -40 < <
Kidney < < < < -14 < < < < <
Liver < < < < < < < < < <
Spleen < < -20 -22 < < < < < <
Blood < < < < < < < < < <71 4 ECTOPIC ANTIBODY PRODUCTION IN PERSISTENT VIRUS INFECTION
TABLE IV
Extent ofInfiltrates, Quantity of CellsProducing Antibodies Against
LCMV (AFC) and Degree ofICD in Parenchymatous Organs of
LCMV CarrierMice ofDifferentStrains
* +, Smallnodulesin the interstice not causing displacement of parenchy-
matous tissue; ++, infiltrates that are so large as to displace parenchy-
matous tissue and to be visible (in stained sections)with the unaidedeye.
(+), No or very few AFC; +, low numbers of AFC with uncertain
quantitative relationship with the animals' age; ++, AFC in essentially
all organs, the numbers of which increase with theanimals' age.
§+, Distension of mesangial space, where lumps of homogeneous PAS-
positive material accumulate, little loss of mesangial cellularity, and
occasionally focal or segmental sclerosis of glomeruli; ++, fully devel-
oped severe lupus-like glomerulonephritis leading to complete hyalini-
zation of glomeruli.
TABLE V
Ratios ofCells ProducingAntibodies against LCMV to Numbers ofCellsProducingAntibodies
with AnySpecificity in Organs ofMice Persistently Infected with LCMV
Mice
NMRI (n = 3, 42 wk old)
Bl O.G (n = 2, 40 wk old)
Neonatal carriermice established by infection within 24 h after birth.
* IgM + IgG + IgA.
$ Numbers per 106 trypan blue-excluding leukocytes, means ±SE.
§Belowdelectability.
Antibody-producing cells*
Organ
LCMV-specific Total Ratio
Brain 603 ± 205* 873 ± 166 0.69
Kidney 459 ± 180 2,242 ± 630 0.21
Liver 190 ± 80 820 ± 141 0.23
Spleen 533 ± 40 14,617 ± 949 0.04
Blood <§ 133 ± 17 -
Brain 1,467 ± 34 2,375 ± 175 0.62
Kidney 700 ± 100 7,800 ± 1,900 0.09
Liver 440 ± 180 1,600 ± 140 0.28
Spleen 1,220 ± 600 37,500 ± 750 0.03
Blood < 135 ± 35 -
Mouse strain H-2 Infil-
trates* AFC* ICD
CBA/J k + + +
C3H/Hej k + + +
AKR/J k + + +
C57BR/cdj k ++ ++ ++
B10.BR/SgSnj k ++ ++ ++
NMRI q ++ ++ ++
SWR/Ola q ++ ++ ++
DBA/1Lacj q ++ ++ ++
B10.G/Ola q ++ ++ ++
C57BL/IOSnj b ++ ++ ++
Housemouse - (+) -MOSKOPHIDIS ET AL.
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expressed view that carrier mice are prone to develop lymphomas (45, 46). We
have analyzed the focal cell accumulations in the parenchymatous organs of
LCMV carrier mice histologically and, by use of a collection of monoclonal
antibodies, immunocytologically, and have come to the conclusion that they
represent functionally active lymphatic tissue (manuscript in preparation). This
finding,andthe existence oflargequantities ofvirus in thesameorgans suggested
the possibility that the lymphoid infiltrates in the parenchymatous organs of
LCMV carrier mice might participate in the humoral antiviral immune response.
This possibility was explored by histological inspection and use of a procedure
for localization and counting of cells producing antiviral antibodies. Our inves-
tigation shows that in persistent LCMV infection (a) a correlation exists in mice
ofdifferent strains and different ages between the degree of ICD on one hand
and numbers and extent of lymphoid cell infiltrates on the other, and that the
magnitude of the latter (as well as the severity of the ICD) increases with the
animals' age; (b) liver, kidney, and braincontain AFC that correspond innumbers
with numbers and dimensions ofthe cell infiltrates; (c) ofthe cells that generate
antibodies of any specificity, the proportion generating antibodies directed
against LCMV is highest in the CNS; and (d) a minority of AFC produce IgM,
which is in line with the previous finding that immune complexes in the kidneys
ofLCMV carrier mice may contain IgM (47).
To our knowledge, this is the first example of a persistent virus infection in
which localization and counting ofantiviral antibody-forming cells in parenchy-
matous tissue has become possible, and we will continue using this model to
study antibody production in organs not belonging to the lymphatic system,
especially the CNS, in virus persistence. At present many questions remain
unanswered. How, for instance, do the cells forming the lymphoid aggregates
enter the CNS? Why is the proportion ofcells forming LCMV-specific antibodies
higher in the CNS than in other organs? Why is the switch to IgG in an
environment in which the immunogen has been present for long periods oftime
not complete? The virologic and immunologic knowledge about the LCMV is
well advanced (27, 48, 49), and we expect that further work will soon give us
answers. One conclusion can be drawn now; the continuous presence of a
powerful immunogen seems to induce the lymphatic system to expand into
organs where it normally does not belong. In the carrier mouse, the virus is
essentially ubiquitous, which may explain why AFC are found in liverand kidney
as well as in the brain. The same may turn out to be the case in illnesses in which
the virus is distributed among various tissues, for instance visna (50), cytomega-
lovirus disease (51), and Aleutian mink disease (52), a speculation that should be
amenable to testing by methods used here. These should also yield an answer to
the question whether, in conditions with predominant or even exclusive localiza-
tion ofthe virus in the brain, such as SSPEor progressiverubella panencephalitis,
antibody production occurs in this organ; in both these diseases infiltrates were
demonstrated in the CNS and assumed, but not proved, to contain cells contrib-
uting to the specific antibodies found in the cerebrospinal fluid (53, 54). It would
also be of interest to determine the organs in which the large quantities of
measles virus-specific Ig that are often present in SSPE (55) are produced.
As pointed out in the introduction, ectopic antibody production, especially in716 ECTOPIC ANTIBODY PRODUCTION IN PERSISTENT VIRUS INFECTION
the CNS, is not a domain ofpersistent virus infections but has also been found
in other infectious diseases, for instance neurosyphilis (14, 15), tuberculous
meningitis (7), during the acute phases of mumps (5, 6) andJapanese flavivirus
encephalitis (9), during and after poliomyelitis (56), and after herpes simplex
virus encephalitis (57). Parainfluenza and Sindbis virus-infected mice have been
proposed to serve as animal models (58, 59). In all these instances, too, it would
be desirable to obtain more direct evidence for intracranial antibody production
than has been so far possible.
Summary
In mice persistently infected with lymphocytic choriomeningitis virus (LCMV),
the parenchymatous organs contain infiltratesofmononuclear cells, the sizes and
numbers of which vary between strains and become more numerous and exten-
sive when the animals grow older. Histologically, these were found to possess a
tissue-like structure, andby useofimmunohistologic procedures they were shown
to contain plasma cells secreting IgM and IgG. Cells of kidneys, livers, brains,
and spleens of LCMV carrier mice were dispersed by digestion with trypsin,
leukocytes were separated by density gradient centrifugation, and numbers of
cells producing antibodies against LCMV were determined by use of a solid-
phase immunoenzymatic technique. In all these organs, cells producing LCMV-
specific IgM and IgG antibodies were demonstrated, the latter more numerous
than the former. Their numbers correlated with numbers and extent of the
lymphoid cell infiltrates. The blood of the same mice was essentially free of
antiviral antibody-forming cell. The proportion of cells producing LCMV-
specific antibodies to all cells producing Ig of any specificity varied between
organs, being lowest in spleen, intermediate in liver and kidney, and highest in
the brain, where in individual mice up to 90% ofall active cells produced virus-
specific antibodies. The LCMV carrier mouse should prove to bea useful animal
model to investigate antibody production in parenchymatous organs during
persistent virus infections.
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